Skip to main content
. 2015 Sep 18;59(10):6188–6194. doi: 10.1128/AAC.00718-15

FIG 3.

FIG 3

Simulated versus observed proportion of subjects receiving tafenoquine for determining relapse-free status at 6 months by country (logistic regression analysis). Left panel, Brazil/Peru; right panel, Thailand.